Cargando…

Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet

Hypertension is frequently comorbid with the disorders of glucose and lipid metabolism. The increased intakes of fructose and salt contribute to the development of hypertension and related metabolic disorders, which are closely associated with gut dysbiosis. Fufang-Zhenzhu-Tiaozhi capsule (FTZ), a t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhe, Yang, Bin, Wang, Zhen, Rong, Xianglu, Zhu, Qing, Guo, Jiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277139/
https://www.ncbi.nlm.nih.gov/pubmed/35846749
http://dx.doi.org/10.3389/fcimb.2022.854849
_version_ 1784745886405885952
author Chen, Zhe
Yang, Bin
Wang, Zhen
Rong, Xianglu
Zhu, Qing
Guo, Jiao
author_facet Chen, Zhe
Yang, Bin
Wang, Zhen
Rong, Xianglu
Zhu, Qing
Guo, Jiao
author_sort Chen, Zhe
collection PubMed
description Hypertension is frequently comorbid with the disorders of glucose and lipid metabolism. The increased intakes of fructose and salt contribute to the development of hypertension and related metabolic disorders, which are closely associated with gut dysbiosis. Fufang-Zhenzhu-Tiaozhi capsule (FTZ), a traditional Chinese patent medicine commonly used in clinical practice, has recently emerged as a promising drug candidate for metabolic diseases. In this study, FTZ treatment is identified as attenuating blood pressure increase and improving the metabolism of lipid and uric acid in high-fructose and high-salt (HFS) diet-fed rats. FTZ also substantially alleviated renal fibrosis and the mRNA expression of inflammation cytokines, NADPH oxidases, and the renin–angiotensin system in the renal cortex. 16S rRNA sequencing of fecal samples revealed that FTZ restored HFS-induced gut dysbiosis, seen as increased intestinal microbial richness and diversity. Furthermore, fecal microbiota transplantation also achieved similar therapeutic effects and alterations in gut microbiota profile induced by FTZ. Taken together, this study highlights the efficacy of FTZ in attenuating HFS-induced hypertension and related metabolic disorders and renal injury. The antihypertensive effect is associated with the modulation of gut microbiota.
format Online
Article
Text
id pubmed-9277139
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92771392022-07-14 Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet Chen, Zhe Yang, Bin Wang, Zhen Rong, Xianglu Zhu, Qing Guo, Jiao Front Cell Infect Microbiol Cellular and Infection Microbiology Hypertension is frequently comorbid with the disorders of glucose and lipid metabolism. The increased intakes of fructose and salt contribute to the development of hypertension and related metabolic disorders, which are closely associated with gut dysbiosis. Fufang-Zhenzhu-Tiaozhi capsule (FTZ), a traditional Chinese patent medicine commonly used in clinical practice, has recently emerged as a promising drug candidate for metabolic diseases. In this study, FTZ treatment is identified as attenuating blood pressure increase and improving the metabolism of lipid and uric acid in high-fructose and high-salt (HFS) diet-fed rats. FTZ also substantially alleviated renal fibrosis and the mRNA expression of inflammation cytokines, NADPH oxidases, and the renin–angiotensin system in the renal cortex. 16S rRNA sequencing of fecal samples revealed that FTZ restored HFS-induced gut dysbiosis, seen as increased intestinal microbial richness and diversity. Furthermore, fecal microbiota transplantation also achieved similar therapeutic effects and alterations in gut microbiota profile induced by FTZ. Taken together, this study highlights the efficacy of FTZ in attenuating HFS-induced hypertension and related metabolic disorders and renal injury. The antihypertensive effect is associated with the modulation of gut microbiota. Frontiers Media S.A. 2022-06-29 /pmc/articles/PMC9277139/ /pubmed/35846749 http://dx.doi.org/10.3389/fcimb.2022.854849 Text en Copyright © 2022 Chen, Yang, Wang, Rong, Zhu and Guo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Chen, Zhe
Yang, Bin
Wang, Zhen
Rong, Xianglu
Zhu, Qing
Guo, Jiao
Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet
title Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet
title_full Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet
title_fullStr Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet
title_full_unstemmed Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet
title_short Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet
title_sort modulation of the gut microbiota by fufang-zhenzhu-tiaozhi capsule attenuates hypertension induced by a high-fructose and high-salt diet
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277139/
https://www.ncbi.nlm.nih.gov/pubmed/35846749
http://dx.doi.org/10.3389/fcimb.2022.854849
work_keys_str_mv AT chenzhe modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet
AT yangbin modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet
AT wangzhen modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet
AT rongxianglu modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet
AT zhuqing modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet
AT guojiao modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet